The Andrew McDonough B+ (Be Positive) Foundation honours the life of Andrew McDonough.  The foundation provides financial and emotional support to families of children with cancer and funds critical, cutting-edge childhood cancer research. For several years, the B+ Foundation has been a major supporter of ACCELERATE, providing transformational support enabling ACCELERATE to serve as the only global forum where all stakeholders—patients, advocates, clinicians, researchers, regulators, and industry—work as equal partners to solve complex challenges in paediatric oncology drug development. 

They lead sector-wide transformation through major support of ACCELERATE's collaborative platform. Their investment powers international convenings, regulatory engagement, and strategic discussions around innovative trial design—turning scientific promise into accessible treatments.

They lead transformation in paediatric oncology through major support of the only platform uniting all stakeholders as equal partners. They drive tangible change through strategic support of ACCELERATE's Paediatric Strategy Forums and Working Groups. Their contributions accelerate the development and prioritization of promising therapies for children with cancer.



They demonstrate sustained commitment to transforming paediatric oncology drug development. Their support enables critical stakeholder convenings and ensures patient advocacy voices shape research priorities and regulatory strategy.

They join a global coalition amplifying impact for children with cancer. These vital contributions help fund ACCELERATE's core operations and ensure broad representation of the paediatric cancer community in drug development conversations.

They are essential voices in ACCELERATE's mission to transform paediatric oncology drug development. Every contribution strengthens our global network and helps ensure children with cancer have access to the collaborative advocacy and research they deserve.